Multi Madison, Wisconsin
"The next generation of DNA sequencing is about to roll off your production line."
And so it happened in June 2019 — the culmination of a two-year mass recruitment of scientists to work for Multi, a biotechnology company building genome-editing technology. Multi is funded by the government of Japan for the purpose of developing a software-related technology for high-level genome editing.
Streaming and Download help